USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Pharmacovigilance and Drug Safety Software Market By Functionality (ADR Reporting, Drug Safety Audits, Issue Tracking, & Fully Integrated Software), By Delivery Mode (On-Premise & On-Demand), By End-User (Pharma & Biotech Companies, CROs, BPOs, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026

Covid-19

Pharmacovigilance and Drug Safety Software Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[187+ Pages Report] According to the latest report titled “Global Pharmacovigilance and Drug Safety Software Market” published by Facts & Factors, the study offers a detailed and comprehensive read. The global pharmacovigilance and drug safety software market witnessed a significant market value of USD 160.2 Million in the year 2020 with a CAGR value of 5.9% to a projected value of USD 205.9 Million in the year 2026.

logoMarket Overview

Pharmacovigilance or drug safety is the definition of a branch of science that deals with the detection, monitoring, assessing, and prevention of harmful effects of the intended pharmaceutical drugs. These software tools mainly help with creating, classifying, and reviewing pharmacovigilance data which helps in creating insights and awareness among the healthcare professionals. Pharmacovigilance software tools are basically used in adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software measures.

logoIndustry Growth Factors

The primary driving forces behind the significant growth during the advent of the forecast period attributes to the rising incidences of adverse drug reactions (ADRs) coupled with increasing adoption of pharmacovigilance software associated with outsourcing the latter into CROs and biotech companies to name a few. Additionally, increased scrutinized measures for prior and post commercialization of drugs coupled with rising complexity related to drug testing measures are expected to increase the footprint of the global pharmacovigilance and drug safety software market during the advent of the forecast period. Moreover, new service launches, agreements, and partnerships coupled with intense software developments coupled with expansive attitude of the key market players will boost the growth of the global pharmacovigilance and drug safety software market during the advent of the forecast period.

The global pharmacovigilance and drug safety software market is driven by rising penetration of the latter tools due to increasing internet connectivity coupled with the rising globalization to name a few. Growing health information functionalities coupled with a shifting trend of manufacturers toward increasing PV and drug safety software will fuel the growth of the global pharmacovigilance and drug safety software market during the advent of the forecast period. However, a lack of a skilled workforce among the pharmacovigilance professionals is expected to decrease the growth of the global pharmacovigilance and drug safety software market during the advent of the forecast period.

Pharmacovigilance and Drug Safety Software Market

logoSegmentation Analysis

The global pharmacovigilance and drug safety software market is segmented into functionality, delivery mode, end-user, and regions.

Based on functionality, the global pharmacovigilance and drug safety software market is classified into ADR reporting, drug safety audits, issue tracking, and fully integrated software. The ADR reporting segment is expected to witness the largest market share during the advent of the forecast owing to data entry & management tools with minimum errors coupled with introduction of advanced data integration solutions to name a few. Based on delivery mode, the global pharmacovigilance and drug safety software market is classified into on-premise and on-demand. The on-premise solutions segment is expected to occupy the largest market share during the advent of the forecast period owing to rising adoption of the latter by large pharmaceutical companies coupled with increased accessibility in the form of remote locations to name a few. The global pharmacovigilance and drug safety software market is fragmented into pharma & biotech companies, CROs, BPOs, and others on the basis of end-user. The segment pertaining to pharma & biotech companies is expected to witness the largest market share during the advent of the forecast period owing to the latter’s ability in facilitating clinical trial programs in order to reduce the burden on medical expenditure coupled with minimizing operational expenses to name a few.

logo Report Scope

Report Attribute

Details

Market Size in 2020

USD 160.2 Million

Projected Market Size in 2026

USD 205.9 Billion

CAGR Growth Rate

5.9% CAGR

Base Year

2020

Forecast Years

2021-2026

Key Market Players

Wipro, TCS, Cognizant, Oracle Corporation, ArisGlobal, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., and Others

Key Segment

Functionality, Delivery Mode, End-Users, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logo Regional Analysis

North America is expected to witness the largest market share during the advent of the forecast period owing to the rising number of government-aided initiatives in favoring adoption of PV software systems coupled with rising surveillance measures for providing relevant data in less time to name a few. Asia-Pacific is expected to witness the fastest growing CAGR during the advent of the forecast period owing to the rise in research outsourcing by pharmaceutical giants coupled with growing public and private investments to name a few. Moreover, the rising number of clinical trials in the region coupled with an increasing number of public safety announcements and initiatives taken by the local and regional government bodies will increase the footprint of the pharmacovigilance and drug safety software market during the advent of the forecast period.

logo Competitive Players

The key market participants for the global pharmacovigilance and drug safety software market are Wipro, TCS, Cognizant, Oracle Corporation, ArisGlobal, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH, Ennov Solutions, Inc., Online Business Applications, Inc., Sarjen Systems Pvt. Ltd., and Umbra Global, among others.

logo By Functionality Segment Analysis

  • ADR Reporting
  • Drug Safety Audits
  • Issue Tracking
  • Fully Integrated Software

logo By Delivery Mode Segment Analysis

  • On-Premise
  • On-Demand

logo By End-User Segment Analysis

  • Pharma & Biotech Companies
  • CROs
  • BPOs
  • Others

logo By Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Covid-19

Pharmacovigilance and Drug Safety Software Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Pharmacovigilance and Drug Safety Software
    2. 1.2. Global Pharmacovigilance and Drug Safety Software Market, 2019 & 2026 (USD Million)
    3. 1.3. Global Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    4. 1.4. Global Pharmacovigilance and Drug Safety Software Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    5. 1.5. Global Pharmacovigilance and Drug Safety Software Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
  2. Chapter 2 Pharmacovigilance and Drug Safety Software Market – Functionality Analysis
    1. 2.1. Global Pharmacovigilance and Drug Safety Software Market – Functionality Overview
    2. 2.2. Global Pharmacovigilance and Drug Safety Software Market Share, by Functionality, 2019 & 2026 (USD Million)
    3. 2.3. ADR Reporting
      1. 2.3.1. Global ADR Reporting Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    4. 2.4. Drug Safety Audits
      1. 2.4.1. Global Drug Safety Audits Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    5. 2.5. Issue Tracking
      1. 2.5.1. Global Issue Tracking Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    6. 2.6. Fully Integrated Software
      1. 2.6.1. Global Fully Integrated Software Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
  3. Chapter 3 Pharmacovigilance and Drug Safety Software Market – Delivery Mode Analysis
    1. 3.1. Global Pharmacovigilance and Drug Safety Software Market – Delivery Mode Overview
    2. 3.2. Global Pharmacovigilance and Drug Safety Software Market Share, by Delivery Mode, 2019 & 2026 (USD Million)
    3. 3.3. On-Premise
      1. 3.3.1. Global On-Premise Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    4. 3.4. On-Demand
      1. 3.4.1. Global On-Demand Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
  4. Chapter 4 Pharmacovigilance and Drug Safety Software Market – End-User Analysis
    1. 4.1. Global Pharmacovigilance and Drug Safety Software Market – End-User Overview
    2. 4.2. Global Pharmacovigilance and Drug Safety Software Market Share, by End-User, 2019 & 2026 (USD Million)
    3. 4.3. Pharma & Biotech Companies
      1. 4.3.1. Global Pharma & Biotech Companies Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    4. 4.4. CROs
      1. 4.4.1. Global CROs Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    5. 4.5. BPOs
      1. 4.5.1. Global BPOs Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    6. 4.6. Others
      1. 4.6.1. Global Others Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
  5. Chapter 5 Pharmacovigilance and Drug Safety Software Market – Regional Analysis
    1. 5.1. Global Pharmacovigilance and Drug Safety Software Market Regional Overview
    2. 5.2. Global Pharmacovigilance and Drug Safety Software Market Share, by Region, 2019 & 2026 (USD Million)
    3. 5.3. North America
      1. 5.3.1. North America Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
        1. 5.3.1.1. North America Pharmacovigilance and Drug Safety Software Market, by Country, 2016 - 2026 (USD Million)
      2. 5.3.2. North America Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026
        1. 5.3.2.1. North America Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      3. 5.3.3. North America Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026
        1. 5.3.3.1. North America Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      4. 5.3.4. North America Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026
        1. 5.3.4.1. North America Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      5. 5.3.5. U.S.
        1. 5.3.5.1. U.S. Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      6. 5.3.6. Canada
        1. 5.3.6.1. Canada Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    4. 5.4. Europe
      1. 5.4.1. Europe Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
        1. 5.4.1.1. Europe Pharmacovigilance and Drug Safety Software Market, by Country, 2016 - 2026 (USD Million)
      2. 5.4.2. Europe Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026
        1. 5.4.2.1. Europe Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      3. 5.4.3. Europe Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026
        1. 5.4.3.1. Europe Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      4. 5.4.4. Europe Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026
        1. 5.4.4.1. Europe Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      5. 5.4.5. Germany
        1. 5.4.5.1. Germany Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      6. 5.4.6. France
        1. 5.4.6.1. France Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      7. 5.4.7. U.K.
        1. 5.4.7.1. U.K. Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      8. 5.4.8. Italy
        1. 5.4.8.1. Italy Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      9. 5.4.9. Spain
        1. 5.4.9.1. Spain Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      10. 5.4.10. Rest of Europe
        1. 5.4.10.1. Rest of Europe Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
        1. 5.5.1.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Country, 2016 - 2026 (USD Million)
      2. 5.5.2. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026
        1. 5.5.2.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      3. 5.5.3. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026
        1. 5.5.3.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      4. 5.5.4. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026
        1. 5.5.4.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      5. 5.5.5. China
        1. 5.5.5.1. China Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      6. 5.5.6. Japan
        1. 5.5.6.1. Japan Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      7. 5.5.7. India
        1. 5.5.7.1. India Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      8. 5.5.8. South Korea
        1. 5.5.8.1. South Korea Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      9. 5.5.9. South-East Asia
        1. 5.5.9.1. South-East Asia Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      10. 5.5.10. Rest of Asia Pacific
        1. 5.5.10.1. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    6. 5.6. Latin America
      1. 5.6.1. Latin America Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
        1. 5.6.1.1. Latin America Pharmacovigilance and Drug Safety Software Market, by Country, 2016 - 2026 (USD Million)
      2. 5.6.2. Latin America Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026
        1. 5.6.2.1. Latin America Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      3. 5.6.3. Latin America Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026
        1. 5.6.3.1. Latin America Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      4. 5.6.4. Latin America Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026
        1. 5.6.4.1. Latin America Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      5. 5.6.5. Brazil
        1. 5.6.5.1. Brazil Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      6. 5.6.6. Mexico
        1. 5.6.6.1. Mexico Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      7. 5.6.7. Rest of Latin America
        1. 5.6.7.1. Rest of Latin America Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
        1. 5.7.1.1. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Country, 2016 - 2026 (USD Million)
      2. 5.7.2. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026
        1. 5.7.2.1. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      3. 5.7.3. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026
        1. 5.7.3.1. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      4. 5.7.4. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026
        1. 5.7.4.1. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      5. 5.7.5. GCC Countries
        1. 5.7.5.1. GCC Countries Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      6. 5.7.6. South Africa
        1. 5.7.6.1. South Africa Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      7. 5.7.7. Rest of Middle-East Africa
        1. 5.7.7.1. Rest of Middle-East Africa Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
  6. Chapter 6 Pharmacovigilance and Drug Safety Software Market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Developments
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. Chapter 7 Company Profiles
    1. 7.1. Wipro
      1. 7.1.1. Company Overview
      2. 7.1.2. Product/Service Portfolio
      3. 7.1.3. Wipro Sales, Revenue, and Gross Margin
      4. 7.1.4. Wipro Revenue and Growth Rate
      5. 7.1.5. Wipro Market Share
      6. 7.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 7.2. TCS
      1. 7.2.1. Company Overview
      2. 7.2.2. Product/Service Portfolio
      3. 7.2.3. TCS Sales, Revenue, and Gross Margin
      4. 7.2.4. TCS Revenue and Growth Rate
      5. 7.2.5. TCS Market Share
      6. 7.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 7.3. Cognizant
      1. 7.3.1. Company Overview
      2. 7.3.2. Product/Service Portfolio
      3. 7.3.3. Cognizant Sales, Revenue, and Gross Margin
      4. 7.3.4. Cognizant Revenue and Growth Rate
      5. 7.3.5. Cognizant Market Share
      6. 7.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 7.4. Oracle Corporation
      1. 7.4.1. Company Overview
      2. 7.4.2. Product/Service Portfolio
      3. 7.4.3. Oracle Corporation Sales, Revenue, and Gross Margin
      4. 7.4.4. Oracle Corporation Revenue and Growth Rate
      5. 7.4.5. Oracle Corporation Market Share
      6. 7.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 7.5. ArisGlobal
      1. 7.5.1. Company Overview
      2. 7.5.2. Product/Service Portfolio
      3. 7.5.3. ArisGlobal Sales, Revenue, and Gross Margin
      4. 7.5.4. ArisGlobal Revenue and Growth Rate
      5. 7.5.5. ArisGlobal Market Share
      6. 7.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 7.6. AB Cube
      1. 7.6.1. Company Overview
      2. 7.6.2. Product/Service Portfolio
      3. 7.6.3. AB Cube Sales, Revenue, and Gross Margin
      4. 7.6.4. AB Cube Revenue and Growth Rate
      5. 7.6.5. AB Cube Market Share
      6. 7.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 7.7. Max Delivery
      1. 7.7.1. Company Overview
      2. 7.7.2. Product/Service Portfolio
      3. 7.7.3. Max Delivery Sales, Revenue, and Gross Margin
      4. 7.7.4. Max Delivery Revenue and Growth Rate
      5. 7.7.5. Max Delivery Market Share
      6. 7.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 7.8. Relsys
      1. 7.8.1. Company Overview
      2. 7.8.2. Product/Service Portfolio
      3. 7.8.3. Relsys Sales, Revenue, and Gross Margin
      4. 7.8.4. Relsys Revenue and Growth Rate
      5. 7.8.5. Relsys Market Share
      6. 7.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 7.9. Sparta Systems Inc
      1. 7.9.1. Company Overview
      2. 7.9.2. Product/Service Portfolio
      3. 7.9.3. Sparta Systems Inc Sales, Revenue, and Gross Margin
      4. 7.9.4. Sparta Systems Inc Revenue and Growth Rate
      5. 7.9.5. Sparta Systems Inc Market Share
      6. 7.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 7.10. United BioSource Corporation
      1. 7.10.1. Company Overview
      2. 7.10.2. Product/Service Portfolio
      3. 7.10.3. United BioSource Corporation Sales, Revenue, and Gross Margin
      4. 7.10.4. United BioSource Corporation Revenue and Growth Rate
      5. 7.10.5. United BioSource Corporation Market Share
      6. 7.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 7.11. EXTEDO GmbH
      1. 7.11.1. Company Overview
      2. 7.11.2. Product/Service Portfolio
      3. 7.11.3. EXTEDO GmbH Sales, Revenue, and Gross Margin
      4. 7.11.4. EXTEDO GmbH Revenue and Growth Rate
      5. 7.11.5. EXTEDO GmbH Market Share
      6. 7.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 7.12. Ennov Solutions Inc
      1. 7.12.1. Company Overview
      2. 7.12.2. Product/Service Portfolio
      3. 7.12.3. Ennov Solutions Inc Sales, Revenue, and Gross Margin
      4. 7.12.4. Ennov Solutions Inc Revenue and Growth Rate
      5. 7.12.5. Ennov Solutions Inc Market Share
      6. 7.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    13. 7.13. Online Business Applications Inc
      1. 7.13.1. Company Overview
      2. 7.13.2. Product/Service Portfolio
      3. 7.13.3. Online Business Applications Inc Sales, Revenue, and Gross Margin
      4. 7.13.4. Online Business Applications Inc Revenue and Growth Rate
      5. 7.13.5. Online Business Applications Inc Market Share
      6. 7.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    14. 7.14. Sarjen Systems Pvt. Ltd
      1. 7.14.1. Company Overview
      2. 7.14.2. Product/Service Portfolio
      3. 7.14.3. Sarjen Systems Pvt. Ltd Sales, Revenue, and Gross Margin
      4. 7.14.4. Sarjen Systems Pvt. Ltd Revenue and Growth Rate
      5. 7.14.5. Sarjen Systems Pvt. Ltd Market Share
      6. 7.14.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    15. 7.15. Umbra Global
      1. 7.15.1. Company Overview
      2. 7.15.2. Product/Service Portfolio
      3. 7.15.3. Umbra Global Sales, Revenue, and Gross Margin
      4. 7.15.4. Umbra Global Revenue and Growth Rate
      5. 7.15.5. Umbra Global Market Share
      6. 7.15.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  8. Chapter 8 Pharmacovigilance and Drug Safety Software — Industry Analysis
    1. 8.1. Introduction and Taxonomy
    2. 8.2. Pharmacovigilance and Drug Safety Software Market – Key Trends
      1. 8.2.1. Market Drivers
      2. 8.2.2. Market Restraints
      3. 8.2.3. Market Opportunities
    3. 8.3. Value Chain Analysis
    4. 8.4. Key Mandates and Regulations
    5. 8.5. Technology Roadmap and Timeline
    6. 8.6. Pharmacovigilance and Drug Safety Software Market – Attractiveness Analysis
      1. 8.6.1. By Functionality
      2. 8.6.2. By Delivery Mode
      3. 8.6.3. By End-User
      4. 8.6.4. By Region
  9. Chapter 9 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 9.1. Pharmacovigilance and Drug Safety Software Industrial Chain Analysis
    2. 9.2. Downstream Buyers
    3. 9.3. Distributors/Traders List
  10. Chapter 10 Marketing Strategy Analysis
    1. 10.1. Marketing Channel
    2. 10.2. Direct Marketing
    3. 10.3. Indirect Marketing
    4. 10.4. Marketing Channel Development Trends
    5. 10.5. Economic/Political Environmental Change
  11. Chapter 11 Report Conclusion & Key Insights
    1. 11.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 11.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  12. Chapter 12 Research Approach & Methodology
    1. 12.1. Report Description
    2. 12.2. Research Scope
    3. 12.3. Research Methodology
      1. 12.3.1. Secondary Research
      2. 12.3.2. Primary Research
      3. 12.3.3. Statistical Models
        1. 12.3.3.1. Company Share Analysis Model
        2. 12.3.3.2. Revenue Based Modeling
      4. 12.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of Pharmacovigilance and Drug Safety Software
      Fig.2	Global Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.3	Global Pharmacovigilance and Drug Safety Software Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.4	Global Pharmacovigilance and Drug Safety Software Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.5	Global Pharmacovigilance and Drug Safety Software Market Share, by Functionality, 2019 & 2026 (USD Million)
      Fig.6	Global ADR Reporting Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.7	Global Drug Safety Audits Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.8	Global Issue Tracking  Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.9	Global Fully Integrated Software Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.10	Global Pharmacovigilance and Drug Safety Software Market Share, by Delivery Mode, 2019 & 2026 (USD Million)
      Fig.11	Global On-Premise  Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.12	Global On-Demand Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.13	Global Pharmacovigilance and Drug Safety Software Market Share, by End-User, 2019 & 2026 (USD Million)
      Fig.14	Global Pharma & Biotech Companies  Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.15	Global CROs Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.16	Global BPOs Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.17	Global Others Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.18	Global Pharmacovigilance and Drug Safety Software Market Share, by Region, 2019 & 2026 (USD Million)
      Fig.19	North America Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.20	U.S. Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.21	Canada Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.22	Europe Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.23	Germany Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.24	France Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.25	U.K. Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.26	Italy Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.27	Spain Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.28	Rest of Europe Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.29	Asia Pacific Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.30	China Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.31	Japan Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.32	India Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.33	South  Korea Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.34	South-East Asia Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.35	Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.36	Latin America Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.37	Brazil Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.38	Mexico Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.39	Rest of Latin America Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.40	The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.41	GCC Countries Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.42	South Africa Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.43	Rest of Middle-East Africa Pharmacovigilance and Drug Safety Software Market, 2016 – 2026 (USD Million)
      Fig.44	Competitor Market Share – Revenue
      Fig.45	Wipro Revenue and Growth Rate
      Fig.46	Wipro Market Share
      Fig.47	TCS Revenue and Growth Rate
      Fig.48	TCS Market Share
      Fig.49	Cognizant Revenue and Growth Rate
      Fig.50	Cognizant Market Share
      Fig.51	Oracle Corporation Revenue and Growth Rate
      Fig.52	Oracle Corporation Market Share
      Fig.53	ArisGlobal Revenue and Growth Rate
      Fig.54	ArisGlobal Market Share
      Fig.55	AB Cube Revenue and Growth Rate
      Fig.56	AB Cube Market Share
      Fig.57	Max Delivery Revenue and Growth Rate
      Fig.58	Max Delivery Market Share
      Fig.59	Relsys Revenue and Growth Rate
      Fig.60	Relsys Market Share
      Fig.61	Sparta Systems Inc Revenue and Growth Rate
      Fig.62	Sparta Systems Inc Market Share
      Fig.63	United BioSource Corporation Revenue and Growth Rate
      Fig.64	United BioSource Corporation Market Share
      Fig.65	EXTEDO GmbH Revenue and Growth Rate
      Fig.66	EXTEDO GmbH Market Share
      Fig.67	Ennov Solutions Inc Revenue and Growth Rate
      Fig.68	Ennov Solutions Inc Market Share
      Fig.69	Online Business Applications Inc Revenue and Growth Rate
      Fig.70	Online Business Applications Inc Market Share
      Fig.71	Sarjen Systems Pvt. Ltd Revenue and Growth Rate
      Fig.72	Sarjen Systems Pvt. Ltd Market Share
      Fig.73	Umbra Global Revenue and Growth Rate
      Fig.74	Umbra Global Market Share
      Fig.75	Market Dynamics
      Fig.76	Global Pharmacovigilance and Drug Safety Software – Value Chain Analysis
      Fig.77	Key Mandates and Regulations
      Fig.78	Technology Roadmap and Timeline
      Fig.79	Market Attractiveness Analysis – By Functionality
      Fig.80	Market Attractiveness Analysis – By Delivery Mode
      Fig.81	Market Attractiveness Analysis – By End-User
      Fig.82	Market Attractiveness Analysis – By Region
      Fig.83	Pharmacovigilance and Drug Safety Software Industrial Chain Analysis
      Fig.84	Market Channels
      Fig.85	Marketing Channel Development Trend
      Fig.86	Growth in World Gross Product, 2008-2018
      

      List of Tables

      Table 1	Global Pharmacovigilance and Drug Safety Software Market, 2019 & 2026 (USD Million)
      Table 2	Global Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      Table 3	Global Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      Table 4	Global Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      Table 5	Global Pharmacovigilance and Drug Safety Software Market, by Region, 2016 – 2026 (USD Million)
      Table 6	North America Pharmacovigilance and Drug Safety Software Market, by Country, 2016 – 2026 (USD Million)
      Table 7	North America Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      Table 8	North America Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      Table 9	North America Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      Table 10 Europe Pharmacovigilance and Drug Safety Software Market, by Country, 2016 – 2026 (USD Million)
      Table 11 Europe Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      Table 12 Europe Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      Table 13 Europe Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      Table 14 Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Country, 2016 – 2026 (USD Million)
      Table 15 Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      Table 16 Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      Table 17 Asia Pacific Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      Table 18 Latin America Pharmacovigilance and Drug Safety Software Market, by Country, 2016 – 2026 (USD Million)
      Table 19 Latin America Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      Table 20 Latin America Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      Table 21 Latin America Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      Table 22 The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Country, 2016 – 2026 (USD Million)
      Table 23 The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Functionality, 2016 – 2026 (USD Million)
      Table 24 The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Delivery Mode, 2016 – 2026 (USD Million)
      Table 25 The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by End-User, 2016 – 2026 (USD Million)
      Table 26 Global Pharmacovigilance and Drug Safety Software Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
      Table 27 Global Pharmacovigilance and Drug Safety Software Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 28 Acquisitions and Mergers
      Table 29 Market Drivers – Impact Analysis
      Table 30 Market Restraints
      Table 31 Market Opportunities
      Table 32 Major Buyers of Pharmacovigilance and Drug Safety Software
      Table 33 Distributors/Traders of Pharmacovigilance and Drug Safety Software by Region
      

Covid-19

Pharmacovigilance and Drug Safety Software Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Wipro
  • TCS
  • Cognizant
  • Oracle Corporation
  • ArisGlobal
  • AB Cube
  • Max Delivery
  • Relsys
  • Sparta Systems Inc.
  • United BioSource Corporation
  • EXTEDO GmbH
  • Ennov Solutions Inc.
  • Online Business Applications Inc.
  • Sarjen Systems Pvt. Ltd.
  • Umbra Global
     

Frequently Asked Questions

The governing factors for the global pharmacovigilance and drug safety software market can be credited to rising incidences of adverse drug reactions (ADRs) coupled with increasing adoption of pharmacovigilance software associated with outsourcing the latter for CROs and biotech companies to name a few
According to Facts & Factors, the global pharmacovigilance and drug safety software market is expected to generate revenue of around USD 205.9 Million by end of 2026, growing at a CAGR of around 5.9% between 2021 and 2026.
North America is expected to witness the largest market share during the advent of the forecast owing to rising number of government-aided initiatives for favoring an adoption of PV software systems coupled with rising surveillance measure for providing relevant data in less time to name a few.
The key market participants for the global pharmacovigilance and drug safety software market are Wipro, TCS, Cognizant, Oracle Corporation, ArisGlobal AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH, and Ennov Solutions, Inc., among others.
why choose fnf
key questions answers

Related Reports

report img

Biohacking Market Report , 2021 – 2026

[197+ Pages Report] The latest report published by Facts Factors titled global biohacking markethas a global perspective on the latter coupled with the market size, volume, drivers, and restraints to name a few. We estimate that the biohacking market will hold a value of USD 14.65 Billion in the ...

Published Date : 06-Aug-2021 | | Category : | Pages : 197 | Format : Read more

Inquiry for Buying Request Sample
report img

Online Pharmacy Market Report s, 2021 – 2028

According to Facts and Factors, The global online pharmacy market size share was estimated at approximately USD 69.25 Billion in 2020 and is expected to generate revenue of around USD 210.35 Billion by the end of 2028, growing at a CAGR of around 17.83% between 2021 and 2028. Global Online Phar...

Published Date : 02-Jun-2021 | | Category : | Pages : 230 | Format : Read more

Inquiry for Buying Request Sample